Navigation Links
Robert Storey Joins VIC Technology Venture Development as Executive in Residence

Fayetteville, AR (PRWEB) February 14, 2013

VIC Technology Venture Development (VIC) is pleased to announce that Robert (Bob) Storey has joined the company as Executive in Residence. Mr. Storey will assist in the assessment and creation of new ventures, then serve as interim CEO for newly formed portfolio companies, especially those focusing on medical devices and engineered materials. In managing these companies, he will provide expertise in business development, marketing, and corporate strategic planning. As CEO for VIC’s startup companies, Mr. Storey will not only manage their operations but will also oversee the development and execution of key commercial milestones, such as resource plans, funding, and recruitment of permanent CEOs and management teams.

“We are indeed fortunate to add Bob’s considerable talents to our development team,” said Calvin Goforth, President and Founder of VIC. “His energy and contributions to the efforts of our young technology companies have been immediately apparent.”

Mr. Storey is no newcomer to the art of new business development. He has over 30 years of experience in this field, especially with startups in regulated industries. Most recently as Executive-in-Residence at Johns Hopkins University, he has helped commercialize technology developed at the University Medical School and the Whiting School of Engineering.

After earning degrees in chemical engineering and chemistry at the University of Arkansas, Mr. Storey took a job with Exxon Corporation. His path led from the Technology Center to Exxon’s American Headquarters in Houston, where he worked in business planning and mergers and acquisitions. He advised Exxon’s Corporate Controller, the Sales and Marketing division, and the leadership of Exxon’s international joint venture with Mitsubishi Petrochemical.

In 1994, Mr. Storey left Exxon to become Vice President and General Manager of a privately held engineering company in Maryland. He led the company through a successful sale to Clariant Corporation of Switzerland, where he served as Vice President of Clariant’s Performance Plastics division.

In 1999, Mr. Storey led Vapotherm, a Maryland company, as President and CEO. The firm, which specialized in non-invasive respiratory devices, received the U.S Commerce Department’s Export Achievement Award, the Maryland World Trade Center International Leadership Award, and Deloitte’s Technology Fast 500 award, four times.
Mr. Storey currently serves on the Dean’s Advisory Council for the University of Arkansas's School of Engineering and is President Emeritus of the Arkansas Academy of Chemical Engineers. He is a Board Member and past President of the Maryland Upper Shore Manufacturing & Business Council, and served on Chesapeake College’s Presidential Search Committee.

About VIC:

VIC Technology Venture Development, LLC is a technology venture development firm that creates innovative new companies with world changing science and engineering based technologies. VIC carefully selects, then licenses technologies from universities and research institutions, then partners technology entrepreneurs with business experts, technology experts and seed stage investors. VIC provides its portfolio companies with senior management expertise, intimate knowledge of technology startups, and proven processes to execute business strategies. Its team members bring extensive experience across legal, financial, operations, marketing, capital acquisition, and technology management areas. VIC experts help their portfolio companies meet management and business planning goals by providing appropriate support at each stage in their development, only as it is needed.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Pittcon Announces 2013 Award Recipients; New Award, Robert Boyle Prize for Analytical Science, Added to Technical Program
2. Robert Haynes To Lead Licensing As VR Laboratories Senior Vice President Product Introduction And Licensing
3. Robert Kirsner, MD, PhD, To Present Results For Phase 2b 6-Month Follow-Up Trial Of Unique Investigational Cell-Based Therapy For Venous Leg Ulcers
4. Fortis Vice President of Nursing Robert Anders Named Academy of Nursing Education Fellow by National League for Nursing
5. Engineer Robert J. Wood to receive NSFs Alan T. Waterman Award
6. Robert Farrell Joins Bionovos Board of Directors
7. Kevin Sharer, Amgen Chairman and CEO, Announces Plan to Retire With Robert Bradway to Become CEO on May 23, 2012; Sharer Will Continue as Chairman of the Board Until End of 2012
8. Michael Berman Joins InspireMD Board
9. Rudy Mazzocchi Joins the Greatbatch Board of Directors as he Continues to Expand his Presence in the Med-tech Industry
10. Diabetes Research Institute Foundation’s (DRIF) CEO Joins Healthcare Holdings Group, Inc. Board of Directors
11. IntelliCell BioSciences Announces Michael Hershman Joins the IntelliCell BioSciences Board of Directors
Post Your Comments:
(Date:11/25/2015)... November 25, 2015 Studies reveal ... human plaque and pave the way for more effective treatment ... cats     --> ... diagnosed health problems in cats, yet relatively little was understood ... collaborative studies have been conducted by researchers from the WALTHAM ...
(Date:11/25/2015)... 25, 2015 Orexigen® Therapeutics, Inc. (Nasdaq: ... a fireside chat discussion at the Piper Jaffray 27th ... . The discussion is scheduled for Wednesday, December 2, ... .  A replay will be available for 14 days ... , Julie NormartVP, Corporate Communications and Business Development , ...
(Date:11/24/2015)... 2015 Cepheid (NASDAQ: CPHD ) today ... following conference, and invited investors to participate via webcast. ...      Tuesday, December 1, 2015 at 11.00 a.m. Eastern Time ...      Tuesday, December 1, 2015 at 11.00 a.m. Eastern Time ... New York, NY      Tuesday, December 1, 2015 ...
(Date:11/24/2015)... 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: ... behalf of the Toronto Stock Exchange, confirms that as ... no corporate developments that would cause the recent movements ... --> About Aeterna Zentaris Inc. ... --> Aeterna Zentaris is a specialty biopharmaceutical company ...
Breaking Biology Technology:
(Date:11/12/2015)... 11, 2015   Growing need for low-cost, ... has been paving the way for use of ... discrete analytes in clinical, agricultural, environmental, food and ... used in medical applications, however, their adoption is ... to continuous emphasis on improving product quality and ...
(Date:11/10/2015)... Nov. 10, 2015 About ... that helps to identify and verify the identity ... considered as the secure and accurate method of ... a particular individual because each individual,s signature is ... especially when dynamic signature of an individual is ...
(Date:11/4/2015)... ALBANY, New York , November 4, 2015 /PRNewswire/ ... According to a new market report published by Transparency ... Size, Share, Growth, Trends and Forecast 2015 - 2022", ... value of US$ 30.3 bn by 2022. The market ... during the forecast period from 2015 to 2022. Rising ...
Breaking Biology News(10 mins):